New edition of definitive resources in tissue engineering

Three of the world's leading authorities in regenerative medicine, Robert Lanza, vice president, research & scientific development for Advanced Cell Technology, Robert Langer, Institute Professor at the Massachusetts Institute for Technology (recent recipient of the National Medal of Science), and Joseph Vacanti, John Homans professor at Harvard Medical School, have released the third edition of Principles of Tissue Engineering, the widely-recognized definitive resource in the field of tissue engineering (Academic Press/Elsevier, August 15, 2007, Hardcover).

Principles of Tissue Engineering, Third Edition provides an update of the rapid progress that has been achieved in the field, combining the prerequisites for a general understanding of tissue growth and development, the tools and theoretical information needed to design tissues and organs, as well as a presentation by the world's experts of what is currently known about each specific organ system. The new edition includes greatly expanded focus on stem cells, including adult and embryonic stem cells and progenitor populations that may soon lead to new tissue engineering therapies for heart disease, diabetes, and a wide variety of other diseases that afflict humanity. This up-to-date coverage of stem cell biology and other emerging technologies is complemented by a series of new chapters on recent clinical experience in applying tissue engineering. The result is a comprehensive textbook that should be useful to students and experts alike.

Principles of Tissue Engineering, Third Edition includes contributions by almost 200 scientists and thought leaders, including Douglas Lauffenburger at the MIT, Bjorn Olsen at the Harvard Medical School, Robert Nerem at Georgia Institute of Technology, Alan Russell at the McGowan Institute for Regenerative Medicine, A Hari Reddi at the University of California Davis, Ioannis Yannas at the MIT, George Whitesides at Harvard University, Alan Trounson at Monash University, Anthony Atala at the Wake Forest Institute for Regenerative Medicine, Charles Vacanti at Harvard Medical School and Massachusetts General Hospital, Eugene Bell at TEI Biosciences, and Laurie Zoloth at Northwestern University, among others.